What Hedge Funds Think About ANSYS, Inc. (ANSS)

Page 1 of 2

Now, according to many investors, hedge funds are assumed to be bloated, old financial vehicles of a forgotten age. Although there are over 8,000 hedge funds trading in present day, this site looks at the crème de la crème of this club, around 525 funds. It is assumed that this group oversees the majority of the hedge fund industry’s total assets, and by monitoring their highest quality equity investments, we’ve unsheathed a number of investment strategies that have historically outperformed Mr. Market. Our small-cap hedge fund strategy outstripped the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outclassed the S&P 500 index by 33 percentage points in 11 months (explore the details and some picks here).

Equally as key, optimistic insider trading activity is a second way to analyze the financial markets. Obviously, there are lots of motivations for an upper level exec to downsize shares of his or her company, but just one, very clear reason why they would buy. Various academic studies have demonstrated the useful potential of this method if investors know what to do (learn more here).

ANSYS, Inc. (NASDAQ:ANSS)

Now that that’s out of the way, we’re going to analyze the newest info surrounding ANSYS, Inc. (NASDAQ:ANSS).

What have hedge funds been doing with ANSYS, Inc. (NASDAQ:ANSS)?

Heading into Q3, a total of 12 of the hedge funds we track held long positions in this stock, a change of 0% from the first quarter. With hedgies’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings considerably.

According to our 13F database, Royce & Associates, managed by Chuck Royce, holds the biggest position in ANSYS, Inc. (NASDAQ:ANSS). Royce & Associates has a $50.7 million position in the stock, comprising 0.2% of its 13F portfolio. Sitting at the No. 2 spot is Sandler Capital Management, managed by Andrew Sandler, which held a $22.8 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Other peers that hold long positions include James A. Noonan’s Pivot Point Capital, Van Schreiber’s Bennett Lawrence Management and Charles Akre’s Akre Capital Management.

Since ANSYS, Inc. (NASDAQ:ANSS) has witnessed a fall in interest from upper-tier hedge fund managers, logic holds that there exists a select few money managers that decided to sell off their positions entirely last quarter. At the top of the heap, Matthew Hulsizer’s PEAK6 Capital Management sold off the largest stake of all the hedgies we key on, totaling about $0.5 million in call options.. Mark A. Nordlicht’s fund, Platinum Management, also said goodbye to its call options., about $0 million worth. These transactions are interesting, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Insider trading activity in ANSYS, Inc. (NASDAQ:ANSS)

Legal insider trading, particularly when it’s bullish, is most useful when the primary stock in question has seen transactions within the past six months. Over the latest 180-day time frame, ANSYS, Inc. (NASDAQ:ANSS) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to ANSYS, Inc. (NASDAQ:ANSS). These stocks are Mentor Graphics Corp (NASDAQ:MENT), PTC Inc (NASDAQ:PMTC), Concur Technologies, Inc. (NASDAQ:CNQR), National Instruments Corp (NASDAQ:NATI), and Autodesk, Inc. (NASDAQ:ADSK). This group of stocks are the members of the technical & system software industry and their market caps are similar to ANSS’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!